Aberrant PI3K/AKT/mTOR signaling is also observed in pathological skin, in particular in cutaneous cancer, as well as in chronic inflammatory diseases, such as psoriasis and atopic dermatitis (AD). The gene discussed is MTOR; the disease is psoriasis.